152 Pimavanserin for the Treatment of Parkinson’s Disease Psychosis: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

CNS Spectrums - United Kingdom
doi 10.1017/s1092852918000469
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Number Needed to Harm Should Be Measured for Treatments

BMJ
1998English

Meta-Analysis, Simpson's Paradox, and the Number Needed to Treat

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2002English

Number Needed to Treat in COPD: Exacerbations Versus Pneumonias

Thorax
PulmonaryRespiratory Medicine
2012English

Quality-Adjusted Life-Years as Decisionmaker Tools to Address Limitations Inherent in Number-Needed-to-Treat/Harm Values

Expert Review of Pharmacoeconomics and Outcomes Research
MedicineHealth PolicyPharmacology
2009English

The Expanded Number Needed to Treat: Applying the Concept of NNT to Continuous Health Economic Outcomes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Reporting Number Needed to Treat and Absolute Risk Reduction in Randomized Controlled Trials

JAMA - Journal of the American Medical Association
Medicine
2002English

Number Needed to Treat Estimates Incorporating Effects Over the Entire Range of Clinical Outcomes—Correction

Archives of Neurology
2004English

Mean Cost Per Number Needed to Treat of Baricitinib Versus Adalimumab in the Treatment of Rheumatoid Arthritis in Italy

Global and Regional Health Technology Assessment
Health Policy
2018English

Pcv20 - Number Needed to Treat for Oral Anti-Coagulants Versus Vka in Stroke Prevention in Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy